Cronos Group Inc. (CRON) Announces C$2.4 Billion Strategic Investment from Altria Group, Inc.
Provides Cronos Group with Additional Capital and Complementary Expertise to Accelerate Its
Expansion and Innovation in the Rapidly Growing Global Cannabis Industry
TORONTO, Dec. 7, 2018...
Cronos Target $3.50 ? (CitronResearch).
(Note, this was written before Cronos confirmed that it is engaged in discussions concerning a potential investment by Altria Group Inc. (MO) ("Altria Group") in...
High Times Reg A+ IPO Is A Mess To Be Avoided (SeekingAlpha).
SummaryRegulation A+ democratized a systematic destruction of investor wealth.Adam Levin, CEO of High Times, has a history of failure.High Times' offering represents a really...
Alkaline Water Co (WTER) $3.90 Approved to Trade on NASDAQ Stock Market December 10th.
Trading to Commence on December 10, 2018
SCOTTSDALE, Ariz., Dec. 04, 2018 (GLOBE NEWSWIRE) -- The Alkaline Water Company Inc. (OTCQB and TSXV: WTER), with products...
The Alkaline Water Company (WTER) to Present at the 11th Annual LD Micro.
SCOTTSDALE, Ariz., Nov. 30, 2018 (GLOBE NEWSWIRE) -- The Alkaline Water Company Inc. (TSXV and OTCQB: WTER), a leading producer of premium bottled alkaline...
How Dangerous are Large Cap Marijuana Stocks Like GW Pharma (GWPH) $122 ? (MarketWatch)
GW Pharmaceuticals’ stock is suffering, even though the biopharmaceutical company has great potential.
GW Pharmaceuticals’ epilepsy drug Epidiolex has the potential to generate over $1...
The Alkaline Water Company Inc. (WTER) Secures Water-Soluble Natural Hemp Extract Formulations
SCOTTSDALE, Ariz., Nov. 29, 2018 (GLOBE NEWSWIRE) -- The Alkaline Water Company Inc. (TSXV and OTCQB: WTER) (the “Company”) announced today that its wholly-owned subsidiary, A88...
Biome Grow (ORTFF $0.59, BIO.C $0.75), Now Publicly Traded but Falling Under the Radar...
(Biome is built to become the next Canadian cannabis conglomerate. Diversified in its holdings, Biome is steered by leaders in the cannabis space -...
Nexien Cannabinoid’s (NXEN) $0.25, Headed to the Ivy Leagues for Testing!
Partnership Will Investigate Advanced Parenteral Cannabinoid-Based Formulations For Acute Treatment of Convulsive Disorders
DENVER, Colo., Nov. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nexien...
Interview: Nexien BioPharma (Symbol: NXEN) CEO, Alex Wasyl.
DENVER, CO / ACCESSWIRE / November 26, 2018 / Nexien BioPharma, Inc. (OTCQB: NXEN) (''Nexien'' or the ''Company'') is a US-based pharmaceutical company focused on the...
